Previous 10 | Next 10 |
home / stock / nriff / nriff news
Growth Company Investor Presentations Now Available for On-Demand Viewing Canada NewsWire NEW YORK, Oct. 12, 2020 Individual and institutional investors as well as advisors are invited to log-on to VirtualInvestorConferences.com to view presentations NEW YO...
Live Growth Opportunities Investor Conference October 8th Company executives will share vision and answer audience questions at VirtualInvestorConferences.com PR Newswire NEW YORK, Oct. 5, 2020 NEW YORK , Oct. 5, 2020 /PRNewswire/ -- Virtual Investor...
Company executives will share corporate vision and answer audience questions at LifeSciencesInvestorForum.com NEW YORK, Sept. 14, 2020 (GLOBE NEWSWIRE) -- Life Sciences Investor Forum today announced the agenda for its quarterly event for public and private companies, investors and ind...
Nuvo Pharmaceuticals® to Webcast Live at Life Sciences Investor Forum September 17th Canada NewsWire MISSISSAUGA, ON, Sept. 14, 2020 - Company invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentatio...
- Combination of sumatriptan succinate and naproxen sodium in a single tablet - MISSISSAUGA, ON , Sept. 9, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI); (OTCQX: NRIFF), a Canadian focused healthcare company with global reach and a diversified ...
Nuvo Pharmaceuticals Inc. (NRIFF) Q2 2020 Earnings Conference Call August 10, 2020, 08:30 AM ET Company Participants Jesse Ledger - President & CEO Kelly Demerino - Interim CFO Conference Call Participants Presentation Operator Good morning, ladies and gentlemen, ...
The following slide deck was published by Nuvo Pharmaceuticals Inc. in conjunction with their 2020 Q2 earnings Read more ...
Nuvo Pharmaceuticals ( OTCQX:NRIFF ) : Q2 Net loss of C$1.97M. More news on: Nuvo Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, , Read more ...
Nuvo Pharmaceuticals® Announces Second Quarter 2020 Results Canada NewsWire MISSISSAUGA, ON, Aug. 10, 2020 ٠ Q2 2020 Adjusted Total Revenue - $18.0 million ٠ ٠ Q2 2020 Adjusted EBITDA - $7.6 million ٠ ٠ ...
MISSISSAUGA, ON , July 27, 2020 /PRNewswire/ - Nuvo Pharmaceuticals Inc. (Nuvo or the Company) (TSX: NRI) (OTCQX: NRIFF), a Canadian-focused healthcare company with global reach and a diversified portfolio of commercial products, today announced it expects to release its second quart...
News, Short Squeeze, Breakout and More Instantly...
Nuvo Research Inc Company Name:
NRIFF Stock Symbol:
OTCMKTS Market:
Miravo HealthcareTM Ireland Enters into Suvexx® License and Supply Agreement with SK Chemicals Co., Ltd. for South Korea Canada NewsWire - First Asian Partnering Deal for Suvexx - - Up to EUR 1.1 million in upfront and milestone payments - ...
Miravo Healthcare™ Ireland Enters into Suvexx® License and Supply Agreement with Orion Corporation for Select EU Markets PR Newswire - First European Partnering Deal for Suvexx - - Up to EUR 1.7 million in upfront and milestone payments -...
Nuvo Pharmaceuticals® Announces Corporate Rebranding as Miravo Healthcare™ - Consolidates to One Single Corporate Brand Identity - MISSISSAUGA, ON , Dec. 18, 2020 /CNW/ - Nuvo Pharmaceuticals Inc. (TSX:NRI) (OTCQX:NRIFF) d/b/...